These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2079302)

  • 1. [Steroid receptor status as prognostic factor in ovarian cancer].
    Schieder K; Biegelmayer C; Kölbl H; Breitenecker G
    Gynakol Rundsch; 1990; 30 Suppl 1():65-7. PubMed ID: 2079302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
    Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
    De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
    Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in breast cancer].
    Jonat W; Eidtmann H; Friedrichs K
    Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
    Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB
    Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
    Prechtel D; Prechtel K
    Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival.
    Isola J; Kallioniemi OP; Korte JM; Wahlström T; Aine R; Helle M; Helin H
    J Pathol; 1990 Dec; 162(4):295-301. PubMed ID: 2290114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
    Bussen S; Rempen A; Caffier H
    Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
    Rose PG; Reale FR; Longcope C; Hunter RE
    Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary.
    Geisler JP; Wiemann MC; Miller GA; Geisler HE
    Gynecol Oncol; 1996 Mar; 60(3):424-7. PubMed ID: 8774651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of steroid hormone receptors in patients with mastopathies and fibroadenomas].
    Meissner J; Kasch R; Splitt G; Gerber B; Rhode E
    Zentralbl Gynakol; 1989; 111(23):1562-6. PubMed ID: 2624008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Receptor status and ovarian function in carcinoma of the breast].
    Giuffrida D; La Porta GA; Sicurella C; La Rosa GL; Milazzo G; Foti E; Marchese V; Lanza C; Vigneri R; Belfiore A
    G Ital Oncol; 1989; 9(2-3):73-6. PubMed ID: 2767731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brenner and transitional cell tumours of the ovary. Report of three cases.
    Rantanen V; Grénman S; Kiilholma P; Salmi T; Klemi PJ
    Ann Chir Gynaecol Suppl; 1994; 208():28-32. PubMed ID: 8092766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognostic implications of sex-steroid receptors in human cancer.
    McCarty KS; Kinsel LB; Georgiade G; Leight G; McCarty KS
    Prog Clin Biol Res; 1990; 322():279-93. PubMed ID: 2304938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrine therapies in breast cancer].
    Schnürch HG
    Gynakologe; 1993 Apr; 26(2):107-17. PubMed ID: 7685309
    [No Abstract]   [Full Text] [Related]  

  • 20. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
    Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
    Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.